Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source.
暂无分享,去创建一个
H Stepp | R Baumgartner | A Hofstetter | H. Stepp | R. Knüchel | R. Baumgartner | W. Beyer | M. Kriegmair | A. Hofstetter | R. Waidelich | R Waidelich | M Kriegmair | R Knüchel | W Beyer | J Schröder | J. Schröder | Martin Kriegmair | Alfons Hofstetter | H. Stepp | R. Knchel | Reinhold Baumgartner | J. Schrder
[1] H Stepp,et al. Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. , 2001, The Journal of urology.
[2] Q. Peng,et al. 5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.
[3] R Baumgartner,et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.
[4] D. Kessel,et al. Hemodynamic effects of 5-aminolevulinic acid in humans. , 1998, Journal of photochemistry and photobiology. B, Biology.
[5] L. Baert,et al. Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. , 1995, Urology.
[6] A. Neuberger,et al. The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N , 1956 .
[7] P Schneede,et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. , 2001, Urology.
[8] T. Wieman,et al. Complications of whole bladder dihematoporphyrin ether photodynamic therapy. , 1989, The Journal of urology.
[9] R. Baumgartner,et al. Integral photodynamic treatment of refractory superficial bladder cancer. , 1995, The Journal of urology.
[10] U. Nseyo,et al. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. , 1998, The Journal of urology.
[11] H Stepp,et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.
[12] M. Snell,et al. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. , 1976, The Journal of urology.
[13] P. Okunieff,et al. Phase I trial of photo dynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder , 1997 .
[14] A. Straughn,et al. Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer. , 2002, The Journal of pharmacology and experimental therapeutics.
[15] E Unsöld,et al. Clinical experience with the integral photodynamic therapy of bladder carcinoma. , 1990, Journal of photochemistry and photobiology. B, Biology.
[16] Manyak Mj. Photodynamic therapy: principles and urologic applications. , 1991 .
[17] R. Knuechel,et al. Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5‐aminolevulinic acid–induced protoporphyrin IX as sensitizer , 2001, International journal of cancer.
[18] The role of photodynamic therapy in the treatment of recurrent superficial bladder cancer. , 2000, The Urologic clinics of North America.
[19] J Moan,et al. 5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.
[20] B. Henderson,et al. PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.
[21] H Stepp,et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors. , 1998, The Journal of urology.
[22] S. C. Chang,et al. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes. , 1996, The Journal of urology.
[23] J. H. Kinsey,et al. Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. , 1983, The Journal of urology.
[24] U. Nseyo,et al. Whole bladder photodynamic therapy: critical review of present-day technology and rationale for development of intravesical laser catheter and monitoring system. , 1990, Urology.
[25] V. Kosma,et al. The morphological changes in rat bladder after photodynamic therapy with 5‐aminolaevulinic acid‐induced protoporphyrin IX , 2000, BJU international.
[26] R Baumgartner,et al. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. , 1994, Urology.